CARDIOTEC

Seoul, South Korea Founded: 1994 • Age: 32 yrs Acquired By Osstem
Drug-eluting stents and PTCA catheters are manufactured for cardiovascular conditions.
Request Access

About CARDIOTEC

CARDIOTEC is a company based in Seoul (South Korea) founded in 1994 was acquired by Osstem in June 2016.. CARDIOTEC operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.

  • Headquarter Seoul, South Korea
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Osstem

    (Jun 01, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of CARDIOTEC

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CARDIOTEC

CARDIOTEC has secured backing from 1 investor. Prominent investors backing the company include Osstem. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Dental implants and kits are manufactured and distributed by Osstem.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CARDIOTEC

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CARDIOTEC

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cardiotec Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CARDIOTEC

CARDIOTEC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Devices for treating peripheral and coronary vascular disease are developed.
domain founded_year HQ Location
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
domain founded_year HQ Location
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
domain founded_year HQ Location
Smart devices for monitoring coronary artery disease are developed.
domain founded_year HQ Location
Embolization devices are developed using Shape Memory Polymer foams.
domain founded_year HQ Location
Developer a system for venous arterialization of the lower limbs
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cardiotec

Frequently Asked Questions about CARDIOTEC

When was CARDIOTEC founded?

CARDIOTEC was founded in 1994.

Where is CARDIOTEC located?

CARDIOTEC is headquartered in Seoul, South Korea.

What does CARDIOTEC do?

Cardiotec produces Drug eluting stents and PTCA catheters for coronary and peripheral vascular diseases. Its products include the DXR Drug Eluting Coronary Stent System, the ILOTAXTM Dual Drug Eluting Coronary Stent System, and the BH PLUS is a Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter. DXR Drug Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions, and the dosage of coated drugs acts reducing restenosis in the lesions. ILOTAXTM Dual Drug Eluting Coronary Stent System is made of L-605 cobalt chromium alloy with coat layers that consist of the antiproliferative drug Paclitaxel, antiplatelet drug Cilostazol, and polymers. BH PLUS is a Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter which is used in a situation like vascular occlusion, narrowing of the coronary arteries, or similar sorts. When the balloon is inflated, it compresses plaque or other foreign substances within a clogged coronary artery which in turn widens. To facilitate insertion of the catheter, the tip of the catheter is narrow, and with radiopaque marker bands, which are used in fluoroscopic examinations, it can be easily placed.

Who are the top competitors of CARDIOTEC?

CARDIOTEC's top competitors include Contego Medical, Limflow and Shape Memory Medical.

Who are CARDIOTEC's investors?

CARDIOTEC has 1 investor. Key investors include Osstem.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available